Exogenous insulin does not reduce protein catabolism in pre-diabetic cystic fibrosis patients: A randomized clinical trial
Journal of Cystic Fibrosis · 2025
DOI: 10.1016/j.jcf.2024.10.005 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cystic Fibrosis, 2025. Verfasst von Michele Schiavon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Information Engineering, University of Padova, Via Gradenigo 6b, 35131, Padova, Italy. Electronic address: michele.schiavon@dei.unipd.i…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Insulin, Glucose Intolerance. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, University of Minnesota.
Abstract (Originalsprache)
BACKGROUND: Cystic Fibrosis (CF) patients historically suffered from undernutrition, infection and inflammation. Insulin insufficiency-related protein catabolism further compromised health. We aimed to determine whether insulin improves protein catabolism in CF youth with abnormal glucose tolerance (AGT). METHODS: This double-masked, placebo-controlled trial in CF youth age 10-25 with AGT who were in their usual state of health used triple-tracer stable-isotope methodology to measure protein turnover during a baseline test meal and after four weeks of insulin/placebo treatment. Healthy controls were assessed once. CF patients were randomized 1:1:1 to once-daily long-acting insulin (0.25 U/kg/d), three-times daily rapid-acting insulin (0.5 U/15gr carbohydrate), or injectable placebo. RESULTS: Thirty CF patients completed the study. There were no differences in any measure of protein turnover between insulin- and placebo-treated subjects, including endogenous protein breakdown (primary study endpoint). In contrast to earlier studies, protein turnover in the 37 CF patients who completed the baseline meal was normal compared to 20 healthy controls. Meal isotope appeared in plasma earlier in CF than controls, suggesting more rapid gut emptying. The study was interrupted by the pandemic; futility analysis led to study discontinuation before the planned remaining 15 CF patients were studied. CONCLUSIONS: Recent advances in CF have led to remarkable clinical improvements. In this study, CF youth with AGT had normal protein catabolism at baseline. Pre-meal or daily basal insulin therapy, while safe and well tolerated, did not significantly enhance protein turnover and does not appear to be necessary in clinically stable patients prior to development of CFRD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Information Engineering, University of Padova, Via Gradenigo 6b, 35131, Padova, Italy. Electronic address: michele.schiavon@dei.unipd.it.
- Department of Woman and Child's Health, University of Padova, Via Giustiniani n 3, 35128, Padova, Italy. Electronic address: cobelli@dei.unipd.it.
- Mayo Clinic College of Medicine, Division of Endocrinology and Research, 200 1st St SW, 5-194 Joseph, Rochester MN 55905. Electronic address: Nair@mayo.edu.
- Mayo Clinic College of Medicine, Division of Endocrinology and Research, 200 1st St SW, 5-194 Joseph, Rochester MN 55905. Electronic address: Klaus.Katherine@mayo.edu.
- Department of Information Engineering, University of Padova, Via Gradenigo 6b, 35131, Padova, Italy. Electronic address: giannamaria.toffolo@unipd.it.
- Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, University Office Plaza, Suite 200, 2221 University Avenue SE, Minneapolis, MN 55414. Electronic address: zhan4800@umn…
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
- University of Minnesota
- National Center for Advancing Translational Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases
- Mayo Clinic
- National Institutes of Health
- Cystic Fibrosis Foundation
Zitieren
APA
Schiavon, M., Cobelli, C., Nair, K. S., Klaus, K., Toffolo, G., Zhang, L., & Moran, A. (2025). Exogenous insulin does not reduce protein catabolism in pre-diabetic cystic fibrosis patients: A randomized clinical trial. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2024.10.005
Vancouver
Schiavon M, Cobelli C, Nair KS, Klaus K, Toffolo G, Zhang L, et al. Exogenous insulin does not reduce protein catabolism in pre-diabetic cystic fibrosis patients: A randomized clinical trial. Journal of Cystic Fibrosis. 2025. doi:10.1016/j.jcf.2024.10.005
BibTeX
@article{Schiavon2025,
author = {Schiavon, Michele and Cobelli, Claudio and Nair, K Sreekumaran and Klaus, Katherine and Toffolo, Gianna and Zhang, Lin and Moran, Antoinette},
title = {Exogenous insulin does not reduce protein catabolism in pre-diabetic cystic fibrosis patients: A randomized clinical trial},
journal = {Journal of Cystic Fibrosis},
year = {2025},
doi = {10.1016/j.jcf.2024.10.005}
}
EUVIMED